NCT02626312 2026-04-16
Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
Clinical Trials
64 trialsNCT03520660 2026-04-14
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
National Institutes of Health Clinical Center (CC)
Phase 4 Active not recruiting
NCT02968810 2026-04-13
Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT06096779 2026-04-03
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT05586516 2026-03-30
A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer
iOnctura
Phase 1/2 Completed
NCT07469319 2026-03-13
BISHOP
University of Aarhus
Phase NA Recruiting
NCT05095714 2026-03-12
FASTRAK
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting
NCT04485286 2026-02-27
Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury
Massachusetts General Hospital
Phase 2 Recruiting
NCT06458998 2026-02-23
GTI
University of Pittsburgh
Phase NA Enrolling by invitation
NCT06061328 2026-02-04
OASIS
VA Office of Research and Development
Phase NA Enrolling by invitation
NCT03654053 2026-01-07
SACRED
VA Office of Research and Development
Phase 3 Active not recruiting
NCT00243633 2025-12-23
Characterization of Focal Liver Lesions by Real-time Contrast-enhanced Ultrasound Imaging (CEUS)
University Hospital, Tours
Phase NA Completed
NCT06007846 2025-09-30
A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Inova Health Care Services
Phase 2/3 Recruiting
NCT05486572 2025-09-26
PREMIUM
VA Office of Research and Development
Phase NA Recruiting
NCT05971108 2025-09-24
REVISE-HCC
Manchester University NHS Foundation Trust
Phase NA Recruiting
NCT07185360 2025-09-22
LIVER-TRACK
Assistance Publique - Hôpitaux de Paris
Phase NA Not yet recruiting
NCT07132515 2025-08-20
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Mansoura University
Phase 4 Recruiting
NCT05433467 2025-08-13
CTMH
Northern Jiangsu People's Hospital
Phase NA Recruiting
NCT07042919 2025-06-29
Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer
Northwestern University
Phase 1/2 Not yet recruiting
NCT03534141 2025-05-16
MHALT
University of California, San Francisco
Phase NA Terminated
NCT05178303 2025-05-16
SB-1121
Trieu, Nguyen Thi, M.D.
Phase 4 Completed
NCT05201404 2025-04-29
LIVERATION
Can-Fite BioPharma
Phase 3 Recruiting
NCT02935478 2025-02-06
Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation
St. Louis University
Phase NA Suspended
NCT03311152 2025-01-14
SEPT9-CROSS
Central Hospital, Nancy, France
Phase NA Completed
NCT04802954 2024-12-18
STARHE
IHU Strasbourg
Phase NA Completed
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT05027425 2024-11-22
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Phase 2 Active not recruiting
NCT02273362 2024-03-26
Erlotinib Hydrochloride in Preventing Liver Cancer in Patients With Cirrhosis of the Liver
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT04248816 2023-02-14
Hepatocellular Carcinoma Surveillance in Cirrhotics
University of Pennsylvania
Phase NA Completed
NCT05449873 2022-10-13
No-touch Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Using Triple Cooled-Wet Electrodes
Seoul National University Hospital
Phase NA Unknown
NCT04499833 2022-06-06
HepatoPredict
Centro Hospitalar de Lisboa Central
Phase NA Recruiting
NCT01798173 2022-04-21
CIRCE
Centre Hospitalier Universitaire Dijon
Phase NA Completed
NCT02224456 2022-02-14
Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
GlaxoSmithKline
Phase 4 Completed
NCT03908255 2022-01-28
BCAA in HCC
Louisiana State University Health Sciences Center in New Orleans
Phase 2 Withdrawn
NCT01387503 2021-10-11
Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase NA Completed
NCT02774161 2021-08-03
B-mode Ultrasound Imaging in Detecting Early Liver Cancer
Stanford University
Phase NA Completed
NCT03342677 2021-04-19
Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility
University Health Network, Toronto
Phase NA Unknown
NCT02854241 2021-03-17
Comparison of Biannual Ultrasonography and Annual Unenhanced Magnetic Resonance Imaging for HCC Surveillance
Seoul National University Hospital
Phase NA Unknown
NCT01264705 2020-11-12
Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
University of Texas Southwestern Medical Center
Phase 1/2 Completed
NCT01486134 2020-05-13
ARMTICH
Assistance Publique - Hôpitaux de Paris
Phase NA Terminated
NCT04006275 2019-09-19
Comparing SonoVue With Sonazoid Using CEUS-LIRADS in HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Unknown
NCT04012021 2019-07-09
EXLIPSE
University of Pisa
Phase NA Unknown
NCT03946852 2019-05-13
Abdominal Regional Perfusion in Donation After Cardiac Death for Multi-Organ Transplantation
London Health Sciences Centre
Phase NA Not yet recruiting
NCT02151864 2019-03-05
LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis
University of California, San Diego
Phase 1 Completed
NCT03853928 2019-02-27
Probiotics in the Prevention of Hepatocellular Carcinoma in Cirrhosis
Austral University, Argentina
Phase NA Unknown
NCT02232490 2019-02-26
Hepko-V5
Immunitor LLC
Phase 3 Unknown
NCT03706846 2018-10-16
GASTROPREP
Centre Hospitalier Universitaire de Besancon
Phase NA Completed
NCT02321202 2018-08-22
Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer
Huazhong University of Science and Technology
Phase 4 Completed
NCT01956864 2018-02-01
Study of High-Dose Oral Vitamin D for the Prevention of Liver Cancer
Johns Hopkins University
Phase 1 Withdrawn
NCT00706576 2017-08-02
Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
University of Missouri-Columbia
Phase 1 Completed